Iris Kanera

2 35 Prevalence and correlates of lifestyle behaviors Table 2.3 Characteristics of the sample ( N = 255) Variable Variable Age years ( SD ) 60.6 (10.7) Type of cancer Gender Breast, n (%) 150 (58.8) Female, n (%) 193 (70.7) Colon, n (%) 51 (20.0) Marital status Other, n (%) 1 54 (21.1) Living with partner, n (%) 217 (86.5) Type of treatment Educational level Surgery alone, n (%) 32 (12.6) Low, n (%) 137 (54.6) Surgery and chemotherapy, n (%) 55 (21.7) Medium, n (%) 47 (18.7) Surgery and radiation therapy, n (%) 46 (18.1) High, n (%) 67 (26.3) Surgery, chemo- & radiation therapy, n (%) 92 (36.2) Employment status Other, n (%) 29 (11.4) Not working, n (%) 158 (64.0) Participation in aftercare Income level Yes, n (%) 134 (53.0) Below average, n (%) 51 (21.1) Number of weeks after treatment, mean ( SD ) 26.5 (12.7) Average, n (%) 70 (28.9) HADS, mean, ( SD ) 8.2 (6.7) Above average, n (%) 121 (50.0) HADS anxiety, mean ( SD ) 4.7 (3.9) BMI, mean ( SD ) 26.7 (9.4) HADS depression, mean ( SD ) 3.5 (3.5) < 18,5: underweight, n (%) 1 (0.4) MAC 18,5-25: healthy weight, n (%) 113 (45.7) Positive adjustment, mean ( SD ) 51.1 (7.0) 25-30: overweight, n (%) 95 (38.5) Negative adjustment, mean ( SD ) 29.6 (7.0) 30-35: obesity, n (%) 25 (10.1) IPQR, mean ( SD ) 32.5 (10.9) > 35: extreme obesity, n (%) 13 (5.3) SPSIR EORTC QLQ-C30 Positive problem orientation, mean ( SD ) 2.4 (0.8) Global health status, mean ( SD ) 78.1 (16.5) Negative problem orientation, mean ( SD ) 1.1 (0.9) Physical functioning, mean ( SD ) 85 (15.3) Alcohol Attitude, mean ( SD ) 2.2 (1.3) Role functioning, mean ( SD ) 79.4 (23.8) Social support, mean ( SD ) 2.2 (1.5) Emotional functioning, mean ( SD ) 80.1 (20.4) Self-efficacy, mean ( SD ) 3.6 (1.3)